Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001203311-14-000034)

Filing Details

Accession Number:: 0001203311-14-000034
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-13 20:42:39
Reporting Period:: 2014-05-09

Filing Date:: 2014-05-13
Accepted Time:: 2014-05-13 20:42:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1060736	Seattle Genetics Inc	SGEN	Biological Products, (No Disgnostic Substances) (2836)	911874389

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1361966	B Vaughn Himes	21823 30Th Drive Se Bothell WA 98021	Evp, Tech. Ops. & Proc. Sci.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-09	10,000	$9.23	65,519	No	4	M	Direct
Common Stock	Disposition	2014-05-09	10,000	$35.00	55,519	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2014-05-09	10,000	$0.00	10,000	$9.23

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
123,664		2019-04-30	No	4	M	Direct

Footnotes

Amount of Securities beneficially owned following reported transactions includes 41,734 Restricted Stock Units subject to vesting.
Shares vested at a rate of 25% on 4/1/2010 and monthly thereafter until all shares were fully vested on 4/1/2013.